Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322842
Status:
COMPLETED
Last Update Posted:
2014-03-13
First Post:
2006-05-04
Brief Title:
Treatment With AMD3100 Plerixafor in Non-Hodgkins Lymphoma and Multiple Myeloma Patients
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
AMD3100-EU21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Medical Monitor
Old Organization:
Genzyme Corporation
Collaborators
| Name | Class |
|---|---|
| AnorMED | INDUSTRY |